Abstract

BackgroundSETDB1 is a histone H3K9 methyltransferase, which plays a significant role in the occurrence and progression of tumors. Previous studies have confirmed that T-lymphom invasion and metastasis gene (Tiam1) is a protein associated with the metastasis of hepatocellular carcinoma (HCC); however, we have not yet been successful in elucidating the specific mechanism of HCC.MethodsYeast two-hybrid test was conducted to screen proteins that interacted with Tiam1 gene. Glutathione-S-transferase (GST) pull-down and crosslinking-immunoprecipitation (CLIP) assays were performed to determine whether SETDB1 can interact with Tiam1 gene. A series of related experiments were performed to explore role of SETDB1 on cell proliferation, migration, and invasion in HCC. Recovery experiment was performed to investigate the effect of Tiam1 knockdown on cell proliferation and migration, which was caused by SETDB1 overexpression in HCC cells. The expression of SETDB1 was frequently upregulated in HCC tissues and positively correlated with Tiam1.ResultsGST pull-down and CLIP assays were performed to elucidate the interaction between SETDB1 and Tiam1. Cell proliferation, migration, and epithelial mesenchymal transformation (EMT) in HCC cells was promoted with the overexpression of SETDB1. Following the knockdown of Tiam1 gene, the effect of SETDB1 on cell proliferation and migration was reversed in HCC cells. The expression of SETDB1 was frequently up-regulated in HCC tissues, and it was positively correlated with Tiam1 gene.ConclusionsOurs is the first study to prove that SETDB1 promotes the proliferation and migration of cells by forming SETDB1-Tiam1 compounds. We found that SETDB1-Tiam1 compounds were involved in a novel pathway, which regulated epigenetic modification of gene expression in HCC samples.

Highlights

  • SETDB1 is a histone H3K9 methyltransferase, which plays a significant role in the occurrence and progression of tumors

  • SETDB1 interacts with T-lymphom invasion and metastasis gene (Tiam1) both in vivo and vitro Mass spectrometry results were identified in vivo and in vitro by GST pull-down and co-immunoprecipitation

  • Compared to adjacent liver tissues, the expression of both SETDB1 and Tiam1 was up-regulated in hepatocellular carcinoma (HCC) samples; there was positive correlation between the expression of SETDB1 and Tiam1

Read more

Summary

Introduction

SETDB1 is a histone H3K9 methyltransferase, which plays a significant role in the occurrence and progression of tumors. Previous studies have confirmed that T-lymphom invasion and metastasis gene (Tiam1) is a protein associated with the metastasis of hepatocellular carcinoma (HCC); we have not yet been successful in elucidating the specific mechanism of HCC. Hepatocellular carcinoma (HCC) is one of the most common malignancies in humans [1]. Metastasis usually occurs in patients with advanced HCC, so it is important to develop new therapeutic targets for successful intervention. We still need to elucidate the underlying molecular mechanisms that mediate metastatic cascade. By further elucidating the molecular mechanism, we can promote the development of effective metastasis-targeted therapy. This would improve the quality of life and survival of patients with HCC

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call